Pricing Log in Create free account

Sagimet Biosciences Inc. (SGMT) vs WAVE Life Sciences Ltd. (WVE)

Sagimet Biosciences Inc. and WAVE Life Sciences Ltd. are both Biotechnology companies. Sagimet Biosciences Inc. and WAVE Life Sciences Ltd. are of similar size ($641.5M and $635.1M). Sagimet Biosciences Inc. has the higher net margin (0.00% vs −296.9%) and the lower return on invested capital (−205.2% vs 0.00%). Across the 13 metrics below, Sagimet Biosciences Inc. leads on 10 and WAVE Life Sciences Ltd. on 3.

Valuation

Metric SGMT WVE Biotechnology median
P/E n/m n/m 10.60
P/S n/m 9.68 9.40
P/B 2.04 1.71 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 3.60 9.02
Earnings yield (13.03%) (31.94%) (32.88%)
Free cash flow yield (8.00%) (30.37%) (23.13%)

Profitability

Metric SGMT WVE Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% (320.94%) 0.00%
Net margin 0.00% (296.86%) 0.00%
Free cash flow margin 0.00% (293.83%) 0.00%
Return on equity (24.37%) (79.98%) (51.96%)
Return on assets (23.49%) (56.19%) (46.06%)
Return on invested capital (205.24%) 0.00% 0.00%

Growth

Metric SGMT WVE Biotechnology median
Revenue growth (TTM) — (35.07%) 6.76%
EPS growth (last fiscal year) (8.97%) (72.86%) 29.88%
Revenue growth, 5-year CAGR — 16.31% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SGMT WVE Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 45.02 8.38 4.97
Net debt to EBITDA 1.98 2.92 1.01

Dividend

Metric SGMT WVE Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric SGMT WVE Biotechnology median
Market cap 641.51m 635.08m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack